Dual epidermal growth factor receptor (EGFR) inhibition: Phase I study combining cetuximab (C225) and erlotinib (E) in advanced solid tumors

Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: d0030866d6a894451dbf0a4c7662c3fffde6f494
First added on: Mar 01, 2025